Showing results (1-10 of 275) with videos related to
Sort By:
Pageof 28
The American Journal of Medicine|December 8, 2020
Decision-Making in the Management of Venous ThromboembolismMartin H Ellis, Orly AvneryLeukemia & Lymphoma|August 16, 2023
Thrombosis in multiple myeloma: mechanisms, risk assessment and managementOsnat Jarchowsky, Orly Avnery, Martin H EllisHarefuah|March 28, 2019
[PRACTICAL ADVICE FOR THE APPROPRIATE USE OF DIRECT ORAL ANTICOAGULANTS]Martin H Ellis, Shirley Shapira, Orly AvneryThe American Journal of Medicine|October 3, 2024
Vitamin K Antagonist Anticoagulation in Antiphospholipid Syndrome: Time in Therapeutic Range and Clinical OutcomesKeren Meir, Stanley Niznik, Orly Avnery, et al.Arthritis Care & Research|May 31, 2021
Ethnicity and Antiphospholipid Syndrome in IsraelStanley Niznik, Micha J Rapoport, Orly Avnery, et al.The American Journal of Medicine|February 19, 2019
Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial FibrillationRonen Arbel, Ruslan Sergienko, Ariel Hammerman, et al.Frontiers in Pharmacology|May 9, 2022
Long Term Follow up of Patients With Primary Obstetric Antiphospholipid SyndromeStanley Niznik, Micha J Rapoport, Orly Avnery, et al.Seminars in Hematology|January 24, 2006
High-dose recombinant factor VIIa therapy in hemophilia patients with inhibitorsGili KenetRheumatology (Oxford, England)|August 12, 2023
Heart valve disease in primary antiphospholipid syndromeStanley Niznik, Micha J Rapoport, Orly Avnery, et al.Frontiers in Immunology|May 6, 2022
Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome-Multicenter, Real-Life Long-Term Follow-UpStanley Niznik, Micha J Rapoport, Orly Avnery, et al.Pageof 28